These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia. Paraskevas GP; Kasselimis D; Kourtidou E; Constantinides V; Bougea A; Potagas C; Evdokimidis I; Kapaki E J Alzheimers Dis; 2017; 55(4):1453-1461. PubMed ID: 27858708 [TBL] [Abstract][Full Text] [Related]
3. Typical and atypical pathology in primary progressive aphasia variants. Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816 [TBL] [Abstract][Full Text] [Related]
4. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia. Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation. Gliebus G; Bigio EH; Gasho K; Mishra M; Caplan D; Mesulam MM; Geula C Neurology; 2010 May; 74(20):1607-10. PubMed ID: 20479359 [TBL] [Abstract][Full Text] [Related]
10. Neuroimaging and biochemical markers in the three variants of primary progressive aphasia. Gil-Navarro S; Lladó A; Rami L; Castellví M; Bosch B; Bargalló N; Lomeña F; Reñé R; Montagut N; Antonell A; Molinuevo JL; Sánchez-Valle R Dement Geriatr Cogn Disord; 2013; 35(1-2):106-17. PubMed ID: 23392204 [TBL] [Abstract][Full Text] [Related]
11. Pathology in primary progressive aphasia syndromes. Harris JM; Jones M Curr Neurol Neurosci Rep; 2014 Aug; 14(8):466. PubMed ID: 24952480 [TBL] [Abstract][Full Text] [Related]
12. Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia. Rohrer JD; Warren JD J Neurol Sci; 2010 Jun; 293(1-2):35-8. PubMed ID: 20400120 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia. Santangelo R; Coppi E; Ferrari L; Bernasconi MP; Pinto P; Passerini G; Comi G; Magnani G J Alzheimers Dis; 2015; 43(4):1429-40. PubMed ID: 25201781 [TBL] [Abstract][Full Text] [Related]
14. Clinical phenotypes and genetic biomarkers of FTLD. Galimberti D; Scarpini E J Neural Transm (Vienna); 2012 Jul; 119(7):851-60. PubMed ID: 22527778 [TBL] [Abstract][Full Text] [Related]
16. Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship. Harciarek M; Kertesz A Neuropsychol Rev; 2011 Sep; 21(3):271-87. PubMed ID: 21809067 [TBL] [Abstract][Full Text] [Related]
17. Comorbid Neurodegeneration in Primary Progressive Aphasia: Clinicopathological Correlations in a Single-Center Study. Rusina R; Bajtosova R; Cséfalvay Z; Keller J; Kavkova A; Kukal J; Matej R Behav Neurol; 2022; 2022():6075511. PubMed ID: 36120397 [TBL] [Abstract][Full Text] [Related]
18. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia. Flanagan EP; Duffy JR; Whitwell JL; Vemuri P; Dickson DW; Josephs KA Neurocase; 2016; 22(1):55-9. PubMed ID: 25929342 [TBL] [Abstract][Full Text] [Related]
19. Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia. Kas A; Uspenskaya O; Lamari F; de Souza LC; Habert MO; Dubois B; Teichmann M; Sarazin M J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):695-8. PubMed ID: 22665450 [TBL] [Abstract][Full Text] [Related]